chrX-85277990-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024921.4(POF1B):c.*1431A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 110,178 control chromosomes in the GnomAD database, including 2,443 homozygotes. There are 6,595 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.22 ( 2441 hom., 6573 hem., cov: 22)
Exomes 𝑓: 0.17 ( 2 hom. 22 hem. )
Consequence
POF1B
NM_024921.4 3_prime_UTR
NM_024921.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.783
Genes affected
POF1B (HGNC:13711): (POF1B actin binding protein) Premature ovarian failure (POF) is characterized by primary or secondary amenorrhea in women less than 40 years old. Two POF susceptibility regions called "POF1" and "POF2" have been identified by breakpoint mapping of X-autosome translocations. POF1 extends from Xq21-qter while POF2 extends from Xq13.3 to Xq21.1. This gene, POF1B, resides in the POF2 region. This gene is expressed at trace levels in mouse prenatal ovary and is barely detectable or absent from adult ovary, in human and in the mouse respectively. This gene's expression is restricted to epithelia with its highest expression in the epidermis, and oro-pharyngeal and gastro-intestinal tracts. The protein encoded by this gene binds non-muscle actin filaments. The role this gene may play in the etiology of premature ovarian failure remains to be determined. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-85277990-T-G is Benign according to our data. Variant chrX-85277990-T-G is described in ClinVar as [Benign]. Clinvar id is 368763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POF1B | NM_024921.4 | c.*1431A>C | 3_prime_UTR_variant | 17/17 | ENST00000262753.9 | NP_079197.3 | ||
POF1B | XM_005262203.5 | c.*1431A>C | 3_prime_UTR_variant | 17/17 | XP_005262260.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POF1B | ENST00000262753 | c.*1431A>C | 3_prime_UTR_variant | 17/17 | 1 | NM_024921.4 | ENSP00000262753.4 |
Frequencies
GnomAD3 genomes AF: 0.215 AC: 23630AN: 109829Hom.: 2443 Cov.: 22 AF XY: 0.201 AC XY: 6537AN XY: 32457
GnomAD3 genomes
AF:
AC:
23630
AN:
109829
Hom.:
Cov.:
22
AF XY:
AC XY:
6537
AN XY:
32457
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.166 AC: 50AN: 302Hom.: 2 Cov.: 0 AF XY: 0.169 AC XY: 22AN XY: 130
GnomAD4 exome
AF:
AC:
50
AN:
302
Hom.:
Cov.:
0
AF XY:
AC XY:
22
AN XY:
130
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.215 AC: 23670AN: 109876Hom.: 2441 Cov.: 22 AF XY: 0.202 AC XY: 6573AN XY: 32514
GnomAD4 genome
AF:
AC:
23670
AN:
109876
Hom.:
Cov.:
22
AF XY:
AC XY:
6573
AN XY:
32514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Premature ovarian failure 2B Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Non-syndromic X-linked intellectual disability Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at